Live News NEWS FLASH L impact Sep 22, 2026, 11:47 AM UTC

LTRN Lantern Pharma Secures USPTO Notice of Allowance for LP—284 Treatment Patent in Aggressive B—Cell Lymphomas

SquawkNews Desk 2 updates Updated Sep 22, 2026, 11:53 AM UTC

Story updates

11:48:27 AM UTC

SquawkNews

LTRN Lantern Pharma Secures USPTO Notice of Allowance for LP-284 Treatment Patent in Aggressive B-Cell Lymphomas

11:53:12 AM UTC

SquawkNews

LTRN - Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas